Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open, Noncomparative Trial of Multidrug Regimens Containing Azithromycin and Rifabutin Administered Three Times Per Week for the Treatment of M. Avium Complex (MAC) Lung Disease

NCT00598962 is registered in ClinicalTrials.gov with The University of Texas Health Science Center at Tyler as lead sponsor.

NCT NCT00598962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00598962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open, Noncomparative Trial of Multidrug Regimens Containing Azithromycin and Rifabutin Administered Three Times Per Week for the Treatment of M. Avium Complex (MAC) Lung Disease
Lead sponsor
The University of Texas Health Science Center at Tyler
Phase
Phase 4
Overall status
Completed
Start date
December 31, 1994
Completion date
May 18, 2017
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mycobacterium avium complex